CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Yuna Rapoport, MD, MPH, of Manhattan Eye, discusses light heat therapy for dry eye disease and lotilaner for Demodex blepharitis.
In her first presentation, Rapoport discussed a post-hoc analysis of the Saturn-1 and Saturn-2 clinical trials. The analysis compared patients who received a vehicle control with those who received Xdemvy (lotilaner ophthalmic solution 0.25%, Tarsus Pharmaceuticals) and assessed whether they experienced improvement.
“Demodex blepharitis is a continuous